Cargando…

Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy

Hepatocellular carcinoma (HCC) is a common, life-threatening complication of longstanding infection with the hepatitis C virus (HCV), likely a consequence of the direct oncogenic activity of the virus cooperating with liver cell inflammation in transforming the liver into a mitogenic and mutagenic e...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Ambrosio, Roberta, Della Corte, Cristina, Colombo, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581320/ https://www.ncbi.nlm.nih.gov/pubmed/26295392 http://dx.doi.org/10.3390/ijms160819698

Ejemplares similares

Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication
por: D’Ambrosio, Roberta, et al.
Publicado: (2021)

Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir
por: D’Ambrosio, Roberta, et al.
Publicado: (2012)

Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
por: D’Ambrosio, Roberta, et al.
Publicado: (2021)

Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon
por: D’Ambrosio, Roberta, et al.
Publicado: (2016)

Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination
por: Lazarus, Jeffrey V., et al.
Publicado: (2023)

Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
por: Sasaki, Reina, et al.
Publicado: (2018)

Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
por: Na, Seong Kyun, et al.
Publicado: (2019)

Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Hepatitis C Virus Deletion Mutants Are Found in Individuals Chronically Infected with Genotype 1 Hepatitis C Virus in Association with Age, High Viral Load and Liver Inflammatory Activity
por: Cheroni, Cristina, et al.
Publicado: (2015)

HEPATOCELLULAR CARCINOMA IN A NON-CIRRHOTIC PATIENT WITH SUSTAINED VIROLOGICAL RESPONSE AFTER HEPATITIS C TREATMENT
por: de MATTOS, Angelo Alves, et al.
Publicado: (2015)

Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma
por: Parikh, Neehar D., et al.
Publicado: (2022)

The impact of antiviral therapy on hepatocellular carcinoma epidemiology
por: Colombo, Massimo, et al.
Publicado: (2018)

Current status of first-line therapy, anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma
por: Alqahtani, Saleh A, et al.
Publicado: (2021)

Obesity and recurrence‐free survival in patients with hepatocellular carcinoma after achieving sustained virological response to interferon therapy for chronic hepatitis C
por: Shinkawa, Hiroji, et al.
Publicado: (2018)

Development of hepatocellular carcinoma in patients with chronic hepatitis C who had sustained viral response following direct-acting antiviral therapy
por: Ebik, Berat, et al.
Publicado: (2022)

Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients
por: Aghemo, Alessio, et al.
Publicado: (2011)

The Association of Il28b Genotype with the Histological Features of Chronic Hepatitis C Is HCV Genotype Dependent
por: D’Ambrosio, Roberta, et al.
Publicado: (2014)

Shear wave elastography predicts hepatocellular carcinoma risk in hepatitis C patients after sustained virological response
por: Hamada, Koichi, et al.
Publicado: (2018)

Development of Hepatocellular Carcinoma in a Patient with Chronic Hepatitis C 21 Years after Achieving a Sustained Virological Response to Interferon Therapy
por: Hara, Tasuku, et al.
Publicado: (2020)

Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C
por: Takata, Kazuhide, et al.
Publicado: (2020)

Interaction between PNPLA3 I148M Variant and Age at Infection in Determining Fibrosis Progression in Chronic Hepatitis C
por: De Nicola, Stella, et al.
Publicado: (2014)

Natural history of hepatocellular carcinoma
por: Colombo, Massimo
Publicado: (2005)

Direct-acting antivirals trigger a favorable, sustained virological response in patients with chronic hepatitis C infections and hepatocellular carcinoma
por: Sohn, Won
Publicado: (2021)

Hepatitis C virus to hepatocellular carcinoma
por: Jahan, Shah, et al.
Publicado: (2012)

Hepatitis C Virus and Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2013)

Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma
por: Plissonnier, Marie-Laure, et al.
Publicado: (2018)

Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index
por: Lee, Keol, et al.
Publicado: (2016)

Clinical Model for Predicting Hepatocellular Carcinomas in Patients with Post-Sustained Virologic Responses of Chronic Hepatitis C: A Case Control Study
por: Zeng, Qing-Lei, et al.
Publicado: (2016)

Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance
por: Griffith, Anna S, et al.
Publicado: (2018)

Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatment
por: Imai, Kenji, et al.
Publicado: (2020)

Characteristics of hepatocellular carcinoma in patients with hepatitis C virus who received direct‐acting antiviral therapy and achieved sustained virological response: The impact of a hepatologist on surveillance
por: Tada, Toshifumi, et al.
Publicado: (2022)

Hepatitis C virus-induced hepatocellular carcinoma
por: Goossens, Nicolas, et al.
Publicado: (2015)

Hepatitis B and C Viruses and Hepatocellular Carcinoma
por: Bartosch, Birke
Publicado: (2010)

Association Between Hepatitis C and Hepatocellular Carcinoma
por: de Oliveria Andrade, Luis Jesuino, et al.
Publicado: (2009)

Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinoma
por: Lin, Wei-Chen, et al.
Publicado: (2020)

Hepatocellular Carcinoma in The Gambia and the role of Hepatitis B and Hepatitis C
por: Mboto, Clement Ibi, et al.
Publicado: (2005)

Tumor aggression among hepatitis-C related hepatocellular carcinoma patients: an observational study regarding the impact of anti-HCV therapy
por: Khalid, Javeria, et al.
Publicado: (2020)

The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy
por: Bae, Bong Kyung, et al.
Publicado: (2016)

Prevention of Hepatocellular Carcinoma Development Associated with Chronic Hepatitis by Anti-Fas Ligand Antibody Therapy
por: Nakamoto, Yasunari, et al.
Publicado: (2002)

Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves
por: El Kassas, Mohamed, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i3lpl52g23340ff2eitfoja444